Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023
Por um escritor misterioso
Descrição
VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi
Fierce Biotech's 2022 Fierce 15
Mark Federici on LinkedIn: Crossbow Therapeutics Launches with $80
見時知幾：2023 年Fierce15 藥企預示着哪些投資趨勢- LongPort
Jacob Perrett on LinkedIn: VC funding update: Which Boston-area
Jacob Perrett on LinkedIn: #analyticaldevelopment #sec
Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences
Bernd Boidol, Autor bei Proxygen
2023“生物技术猛公司”榜单火热出炉，它们带来了哪些突破? - 知乎
Fierce Life Sciences Events on LinkedIn: Fierce Clinical Summit
Mark Federici on LinkedIn: Crossbow Therapeutics Launches with $80
Fierce Biotech on LinkedIn: Biotech's women leaders decry US
Fierce Life Sciences Events on LinkedIn: The Future of Biotech
Jacob Perrett on LinkedIn: VC funding update: Which Boston-area
Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences
Introducing Fierce Biotech's 2023 Fierce 15
de
por adulto (o preço varia de acordo com o tamanho do grupo)
